Carvedilol in the treatment of elderly patients with chronic heart failure
Klaus KA Witte1, Andrew L Clark21Academic Department of Cardiology, LIGHT Building, University of Leeds and Leeds General Infirmary, UK; 2Academic Department of Cardiology, Castle Hill Hospital, University of Hull, Hull, UKAbstract: Chronic heart failure (CHF) is common, and increases in incidence a...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2008
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/4489500f74044df798aa28c82bbfd687 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Klaus KA Witte1, Andrew L Clark21Academic Department of Cardiology, LIGHT Building, University of Leeds and Leeds General Infirmary, UK; 2Academic Department of Cardiology, Castle Hill Hospital, University of Hull, Hull, UKAbstract: Chronic heart failure (CHF) is common, and increases in incidence and prevalence with age. There are compelling data demonstrating reduced mortality and hospitalizations with adrenergic blockade in older patients with CHF. Despite this, many older patients remain undertreated. The aim of the present article is to review the potential mechanisms of the benefits of adrenergic blockade in CHF and the clinical data available from the large randomized studies, focusing particularly on older patients.Keywords: beta-blockers, chronic heart failure |
|---|